Zhihong Chi

A phase II study of RC48-ADC in HER2-negative patients with locally advanced or metastatic urothelial carcinoma.

Huayan Xu, Xinan Sheng, Li Zhou et al. · Journal of Clinical Oncology · 2022 · 38 citations

Medicine, Pharmacology, Pharmacotherapy +16

HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population

Li Zhou, Zhiting Shao, Yiqiang Liu et al. · The Oncologist · 2023 · 28 citations · Full text

Medicine, Oncology, Pathology +15

Preliminary results of a phase Ib/II combination study of RC48-ADC, a novel humanized anti-HER2 antibody-drug conjugate (ADC) with toripalimab, a humanized IgG4 mAb against programmed death-1 (PD-1) in patients with locally advanced or metastatic urothelial carcinoma.

Xinan Sheng, Li Zhou, Zhisong He et al. · Journal of Clinical Oncology · 2022 · 27 citations

Medicine, Oncology, Pharmacology +17

Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell Carcinoma

Xieqiao Yan, Li Zhou, Siming Li et al. · Clinical Genitourinary Cancer · 2022 · 19 citations

Medicine, Cancer Biology, Oncology +12